中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
18期
19-19,21
,共2页
瑞舒伐他汀%进展性脑梗死%神经功能缺损程度评分%动脉粥样硬化
瑞舒伐他汀%進展性腦梗死%神經功能缺損程度評分%動脈粥樣硬化
서서벌타정%진전성뇌경사%신경공능결손정도평분%동맥죽양경화
Rosuvastatin%Progressive cerebral infarction%Nerve deficiency scale%Atherosclerosis
目的：探讨瑞舒伐他汀在进展性脑梗死治疗中的应用价值。方法：2012年1月-2013年10月收治进展性脑梗死患者76例，按照分层随机法分为观察组38例和对照组38例，对照组给予常规治疗，主要包括保护脑细胞、控制血压、抗血小板等治疗；观察组在对照组治疗的基础上给予瑞舒伐他汀20mg 口服，1次/日，连续治疗6周为1疗程。结果：两组治疗后NIHSS评分均有下降，治疗后观察组较对照组下降明显，差异有统计学意义(P＜0.05)；治疗后观察组总有效率86.8%，对照组总有效率65.7%，两组比较差异有统计学意义(P＜0.05)。结论：瑞舒伐他汀治疗进展性脑梗死可有效阻断脑梗死的进展，改善进展性脑梗死的预后。
目的：探討瑞舒伐他汀在進展性腦梗死治療中的應用價值。方法：2012年1月-2013年10月收治進展性腦梗死患者76例，按照分層隨機法分為觀察組38例和對照組38例，對照組給予常規治療，主要包括保護腦細胞、控製血壓、抗血小闆等治療；觀察組在對照組治療的基礎上給予瑞舒伐他汀20mg 口服，1次/日，連續治療6週為1療程。結果：兩組治療後NIHSS評分均有下降，治療後觀察組較對照組下降明顯，差異有統計學意義(P＜0.05)；治療後觀察組總有效率86.8%，對照組總有效率65.7%，兩組比較差異有統計學意義(P＜0.05)。結論：瑞舒伐他汀治療進展性腦梗死可有效阻斷腦梗死的進展，改善進展性腦梗死的預後。
목적：탐토서서벌타정재진전성뇌경사치료중적응용개치。방법：2012년1월-2013년10월수치진전성뇌경사환자76례，안조분층수궤법분위관찰조38례화대조조38례，대조조급여상규치료，주요포괄보호뇌세포、공제혈압、항혈소판등치료；관찰조재대조조치료적기출상급여서서벌타정20mg 구복，1차/일，련속치료6주위1료정。결과：량조치료후NIHSS평분균유하강，치료후관찰조교대조조하강명현，차이유통계학의의(P＜0.05)；치료후관찰조총유효솔86.8%，대조조총유효솔65.7%，량조비교차이유통계학의의(P＜0.05)。결론：서서벌타정치료진전성뇌경사가유효조단뇌경사적진전，개선진전성뇌경사적예후。
Objective:To explore the application value of rosuvastatin in the treatment of progressive cerebral infarction.Methods:76 cases with progressive cerebral infarction were selected from January 2012 to October 2013.They were randomly divided into the observation group with 38 cases and the control group with 38 cases.The control group were given the conventional treatment, including protecting brain cells,controlling blood pressure,antiplatelet therapy.The observation group were given 20mg rosuvastatin oral on the basis of the control group treatment,1 time one day,continuous treatment for 1 course of 6 weeks.Results:The NIHSS scores of the two groups after treatment were decreased.After treatment,the observation group decreased more significantly than the control group,and there was significant difference(P<0.05).After treatment,the total effective rate of the observation group was 86.8%.The total effective rate of the control group was 65.7%.There was significant difference between two groups(P<0.05).Conclusion:Rosuvastatin in the treatment of progressive cerebral infarction can effectively block the development of cerebral infarction,and improve the prognosis of progressive cerebral infarction.
